
Wren Capital
Description
Wren Capital LLP is a nascent seed and early-stage investment fund based in London, United Kingdom, established in 2023. The firm positions itself as a crucial early backer for promising UK-based technology companies. With a strategic focus on the burgeoning deep tech, artificial intelligence (AI), and enterprise software sectors, Wren Capital aims to identify and nurture innovative startups poised for significant growth. Its recent inception underscores a commitment to contributing to the vibrant UK tech ecosystem, providing essential capital at the foundational stages of company development.
The fund's investment strategy is centered on providing initial capital to companies demonstrating strong potential within its core areas of interest. Wren Capital typically deploys first cheques ranging from £250,000 to £1,000,000. This investment size indicates their commitment to supporting companies through their critical early development phases, enabling them to achieve key milestones and attract subsequent funding rounds. The firm's hands-on approach likely involves more than just capital, offering strategic guidance and network access to its portfolio companies.
Wren Capital's geographic mandate is firmly rooted in the United Kingdom, specifically targeting companies within its borders. This localized focus allows the fund to develop deep expertise in the UK market dynamics and build strong relationships with founders and co-investors in the region. By concentrating on deep tech, AI, and enterprise software, Wren Capital aligns itself with some of the most transformative technological trends, seeking to back ventures that are developing proprietary, defensible technologies with significant market potential. The fund's relatively recent establishment in 2023 suggests a fresh perspective and agility in navigating the evolving landscape of early-stage venture capital.
Investor Profile
Wren Capital has backed more than 31 startups, with 1 new investments in the last 12 months alone. The firm has led 0 rounds, about 0% of its total and boasts 3 exits across its portfolio.
Investment Focus Highlights
- Concentrates on Seed, Series Unknown, Series A rounds (top funding stages).
- Majority of deals are located in United Kingdom.
- Strong thematic focus on Biotechnology, Health Care, Biopharma.
- Typical check size: $317.5K – $1.3M.
Stage Focus
- Seed (35%)
- Series Unknown (26%)
- Series A (26%)
- Angel (6%)
- Pre Seed (3%)
- Equity Crowdfunding (3%)
Country Focus
- United Kingdom (100%)
Industry Focus
- Biotechnology
- Health Care
- Biopharma
- Genetics
- Therapeutics
- Hardware
- Medical
- Medical Device
- Pharmaceutical
- Health Diagnostics
Frequently Asked Questions
Learn who this investor regularly partners with—both firms and angels—and explore their latest activity.